Nicolas Martinenghi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicolas Martinenghi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alex Pacheco-Bouthillier
Inst Cardiovasc Minima Invas, Guadalajara, Mexico
1 shared publication - Alicia Sale
Medtronic, Minneapolis, MN USA
1 shared publication - Andres Nicolas Atamañuk
Inherited Heart Disease Clinic, Hospital General de Agudos “Dr. Juan A. Fernández”, Cerviño 3356, C1425AGP Buenos Aires
1 shared publication - Armando Perez-Silva
Hospital Regional de Concepcion Department of Cardiology Concepcion
1 shared publication - Daniela Paredes-Fernández
Univ Nacl Andres Bello, Nucleo Acad Inst Salud Publ, Santiago, Chile
1 shared publication - Juan Fernando Agudelo Uribe
Hemodynamics and Interventional Cardiology Department CardioVID Clinic Medellín Antioquia Colombia
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Cardiology
- Vol. 2026 (1)
Recurrent Ventricular Tachycardia in a Young Adult—Imaging and Genetic Evidence of DSP ‐Associated Arrhythmogenic Cardiomyopathy: A Case Report
Background: Ventricular tachycardia (VT) may represent the first manifestation of inherited cardiomyopathies, particularly in young patients without overt structural heart disease. Arrhythmogenic cardiomyopathy (ACM) is an inherited myocardial disorder characterized by ventricular arrhythmias, fibrofatty myocardial replacement, and an increased risk of sudden cardiac death. Pathogenic variants in the desmoplakin (DSP) gene have been increasingly associated with left‐dominant or biventricular forms of ACM and inflammatory “hot phases” of myocardial injury. Case Presentation: We report the case of a 37‐year‐old male presenting with sustained monomorphic VT with right ventricular outflow tract morphology requiring synchronized electrical cardioversion. Electrocardiography in sinus rhythm demonstrated low‐voltage limb leads and T‐wave inversion in V1–V3. Echocardiography showed mildly reduced right ventricular function with dyskinesia of the RV free wall (TAPSE 17 mm, RV S ′ 10 cm/s). Cardiac magnetic resonance revealed mild RV dilation and subepicardial late gadolinium enhancement in the lateral left ventricular wall with mild pericardial involvement, consistent with an ACM‐related inflammatory phenotype. An implantable cardioverter defibrillator was implanted for secondary prevention. Genetic testing identified a heterozygous pathogenic DSP frameshift variant (c.1009_1010dup; p.Leu338Serfs36∗), confirming the diagnosis of DSP‐related ACM. Conclusion: This case highlights the importance of integrating electrocardiography, multimodality imaging, and genetic testing in the evaluation of VT in young adults. Identification of a pathogenic DSP variant confirmed the diagnosis of ACM and has important implications for arrhythmic risk stratification and family screening.
- 1 January 2026
- Published by Wiley in Case Reports in Cardiology
- Vol. 2026 (1)
Open AccessRecurrent Ventricular Tachycardia in a Young Adult—Imaging and Genetic Evidence of DSP ‐Associated Arrhythmogenic Cardiomyopathy: A Case Report
Background: Ventricular tachycardia (VT) may represent the first manifestation of inherited cardiomyopathies, particularly in young patients without overt structural heart disease. Arrhythmogenic cardiomyopathy (ACM) is an inherited myocardial disorder characterized by ventricular arrhythmias, fibrofatty myocardial replacement, and an increased risk of sudden cardiac death. Pathogenic variants in the desmoplakin (DSP) gene have been increasingly associated with left‐dominant or biventricular forms of ACM and inflammatory “hot phases” of myocardial injury. Case Presentation: We report the case of a 37‐year‐old male presenting with sustained monomorphic VT with right ventricular outflow tract morphology requiring synchronized electrical cardioversion. Electrocardiography in sinus rhythm demonstrated low‐voltage limb leads and T‐wave inversion in V1–V3. Echocardiography showed mildly reduced right ventricular function with dyskinesia of the RV free wall (TAPSE 17 mm, RV S ′ 10 cm/s). Cardiac magnetic resonance revealed mild RV dilation and subepicardial late gadolinium enhancement in the lateral left ventricular wall with mild pericardial involvement, consistent with an ACM‐related inflammatory phenotype. An implantable cardioverter defibrillator was implanted for secondary prevention. Genetic testing identified a heterozygous pathogenic DSP frameshift variant (c.1009_1010dup; p.Leu338Serfs36∗), confirming the diagnosis of DSP‐related ACM. Conclusion: This case highlights the importance of integrating electrocardiography, multimodality imaging, and genetic testing in the evaluation of VT in young adults. Identification of a pathogenic DSP variant confirmed the diagnosis of ACM and has important implications for arrhythmic risk stratification and family screening.
- 2 September 2024
- Published by Medwave Estudios Limitada in Medwave
- Vol. 24 (08) , e2918
Electrophysiology lab efficiency using cryoballoon for pulmonary vein isolation in Latin America: A sub-analysis of the Cryo Global Registry Study
Objective Cryoballoon ablation for pulmonary vein isolation is a time-efficient procedure that can alleviate stress on electrophysiology lab resources. This analysis modeled the impact of cryoballoon ablation on electrophysiology lab operation using data from Latin America. Methods Data from centers in Argentina, Mexico, Colombia, and Chile of the were used as inputs for an electrophysiology lab efficiency simulation model. The model used the assumption that either two (today’s electrophysiology lab operations) or three (including electrophysiology lab operational changes) cryoballoon ablation procedures could be performed per day. The endpoints were the percentage of days that resulted in 1) overtime and 2) time left for an extra non-ablation electrophysiology procedure. Results Data from a total of 232 procedures from six Latin American centers were included in the analysis. The average electrophysiology lab occupancy time for all procedures in Latin America was 132 ± 62 minutes. In the Current Scenario (two procedures per day), 7.4% of simulated days resulted in overtime, and 81.4% had enough time for an extra electrophysiology procedure. In the Enhanced Productivity Scenario (three procedures per day), 16.4% of days used overtime, while 67.4% allowed time for an extra non-ablation electrophysiology procedure. Conclusions Using real-world, Latin American-specific data, we found that with operational changes, three ablation procedures could feasibly be performed daily, leaving time for an extra electrophysiology procedure on more than half of days. Thus, use of cryoballoon ablation is an effective tool to enhance electrophysiology lab efficiency in resource-constrained regions such as Latin America.
- 2 September 2024
- Published by Medwave Estudios Limitada in Medwave
- Vol. 24 (08) , e2918
Electrophysiology lab efficiency using cryoballoon for pulmonary vein isolation in Latin America: A sub-analysis of the Cryo Global Registry Study
Objective Cryoballoon ablation for pulmonary vein isolation is a time-efficient procedure that can alleviate stress on electrophysiology lab resources. This analysis modeled the impact of cryoballoon ablation on electrophysiology lab operation using data from Latin America. Methods Data from centers in Argentina, Mexico, Colombia, and Chile of the were used as inputs for an electrophysiology lab efficiency simulation model. The model used the assumption that either two (today’s electrophysiology lab operations) or three (including electrophysiology lab operational changes) cryoballoon ablation procedures could be performed per day. The endpoints were the percentage of days that resulted in 1) overtime and 2) time left for an extra non-ablation electrophysiology procedure. Results Data from a total of 232 procedures from six Latin American centers were included in the analysis. The average electrophysiology lab occupancy time for all procedures in Latin America was 132 ± 62 minutes. In the Current Scenario (two procedures per day), 7.4% of simulated days resulted in overtime, and 81.4% had enough time for an extra electrophysiology procedure. In the Enhanced Productivity Scenario (three procedures per day), 16.4% of days used overtime, while 67.4% allowed time for an extra non-ablation electrophysiology procedure. Conclusions Using real-world, Latin American-specific data, we found that with operational changes, three ablation procedures could feasibly be performed daily, leaving time for an extra electrophysiology procedure on more than half of days. Thus, use of cryoballoon ablation is an effective tool to enhance electrophysiology lab efficiency in resource-constrained regions such as Latin America.